This study involves patients treated with cisplatin and etoposide (induction therapy),
followed by treatment with a drug called S1 (maintenance therapy). The main purpose of this
study is to determine if this type of treatment will delay the growth of the tumor and if so,
for how long. The primary endpoint is progression free survival and second endpoints are
toxicities, overall survival.